UA104611C2 - Aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitors - Google Patents
Aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitorsInfo
- Publication number
- UA104611C2 UA104611C2 UAA201110177A UAA201110177A UA104611C2 UA 104611 C2 UA104611 C2 UA 104611C2 UA A201110177 A UAA201110177 A UA A201110177A UA A201110177 A UAA201110177 A UA A201110177A UA 104611 C2 UA104611 C2 UA 104611C2
- Authority
- UA
- Ukraine
- Prior art keywords
- lower alkyl
- halogen
- heteroaryl
- substituted
- lower alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09151382 | 2009-01-27 | ||
| PCT/EP2010/050551 WO2010086251A1 (en) | 2009-01-27 | 2010-01-19 | Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA104611C2 true UA104611C2 (en) | 2014-02-25 |
Family
ID=41718529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201110177A UA104611C2 (en) | 2009-01-27 | 2010-01-19 | Aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitors |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20100197715A1 (ru) |
| EP (1) | EP2391603B1 (ru) |
| JP (1) | JP5552494B2 (ru) |
| KR (1) | KR101289577B1 (ru) |
| CN (1) | CN102292320B (ru) |
| AR (1) | AR075160A1 (ru) |
| AU (1) | AU2010209816A1 (ru) |
| BR (1) | BRPI1007410A2 (ru) |
| CA (1) | CA2746967A1 (ru) |
| CO (1) | CO6341621A2 (ru) |
| CR (1) | CR20110348A (ru) |
| EC (1) | ECSP11011196A (ru) |
| ES (1) | ES2445143T3 (ru) |
| IL (1) | IL213672A0 (ru) |
| MA (1) | MA32947B1 (ru) |
| MX (1) | MX2011007272A (ru) |
| NZ (1) | NZ593279A (ru) |
| PE (1) | PE20120500A1 (ru) |
| RU (1) | RU2517701C2 (ru) |
| SG (1) | SG173116A1 (ru) |
| TW (1) | TWI403322B (ru) |
| UA (1) | UA104611C2 (ru) |
| WO (1) | WO2010086251A1 (ru) |
| ZA (1) | ZA201104237B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20120500A1 (es) | 2009-01-27 | 2012-05-04 | Hoffmann La Roche | Piperidinas sustituidas con heteroilamino y aroilamino como inhibidores de glyt-1 |
| US8658639B2 (en) * | 2009-06-24 | 2014-02-25 | Dainippon Sumitomo Pharma Co., Ltd | N-substituted-cyclic amino derivative |
| US20140155419A1 (en) * | 2011-07-29 | 2014-06-05 | Erkan Baloglu | Compounds and methods |
| US9012489B2 (en) | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| EP4054551A4 (en) * | 2019-11-07 | 2024-03-20 | Univ Illinois | INFLUENZA VIRAL ENTRY INHIBITORS |
| CN114478360B (zh) * | 2022-02-10 | 2023-08-15 | 江苏海洋大学 | 一种苯甲酰胺类衍生物及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2600557A1 (de) * | 1976-01-09 | 1977-07-14 | Delmar Chem | 4-aryl-3/4-amino/hydroxy-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| EP1296950A2 (en) | 2000-04-20 | 2003-04-02 | NPS Allelix Corp. | Aminopiperidines for use as glyt-1 inhibitors |
| WO2002080928A1 (en) * | 2001-04-03 | 2002-10-17 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| CA2515838A1 (en) * | 2003-02-17 | 2004-08-26 | F. Hoffmann-La Roche Ag | Piperidine-benzenesulfonamide derivatives |
| FR2861071B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique |
| FR2861074B1 (fr) * | 2003-10-17 | 2006-04-07 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| CN100467468C (zh) | 2003-10-23 | 2009-03-11 | 弗·哈夫曼-拉罗切有限公司 | 在治疗神经学和神经精神病学紊乱中用作glyt-1抑制剂的三氮杂-螺哌啶衍生物 |
| JPWO2008093737A1 (ja) * | 2007-01-31 | 2010-05-20 | 大日本住友製薬株式会社 | アミド誘導体 |
| UA41251U (ru) * | 2008-12-26 | 2009-05-12 | Яков Семенович Песиков | Способ лечения алкоголизма |
| PE20120500A1 (es) | 2009-01-27 | 2012-05-04 | Hoffmann La Roche | Piperidinas sustituidas con heteroilamino y aroilamino como inhibidores de glyt-1 |
-
2010
- 2010-01-19 PE PE2011001308A patent/PE20120500A1/es not_active Application Discontinuation
- 2010-01-19 WO PCT/EP2010/050551 patent/WO2010086251A1/en active Application Filing
- 2010-01-19 CA CA2746967A patent/CA2746967A1/en not_active Abandoned
- 2010-01-19 UA UAA201110177A patent/UA104611C2/ru unknown
- 2010-01-19 KR KR1020117019722A patent/KR101289577B1/ko not_active IP Right Cessation
- 2010-01-19 BR BRPI1007410A patent/BRPI1007410A2/pt not_active Application Discontinuation
- 2010-01-19 RU RU2011134960/04A patent/RU2517701C2/ru not_active IP Right Cessation
- 2010-01-19 JP JP2011546772A patent/JP5552494B2/ja not_active Expired - Fee Related
- 2010-01-19 CN CN201080005279.2A patent/CN102292320B/zh not_active Expired - Fee Related
- 2010-01-19 AU AU2010209816A patent/AU2010209816A1/en not_active Abandoned
- 2010-01-19 NZ NZ593279A patent/NZ593279A/xx not_active IP Right Cessation
- 2010-01-19 ES ES10700563.9T patent/ES2445143T3/es active Active
- 2010-01-19 SG SG2011053360A patent/SG173116A1/en unknown
- 2010-01-19 MA MA33992A patent/MA32947B1/fr unknown
- 2010-01-19 MX MX2011007272A patent/MX2011007272A/es active IP Right Grant
- 2010-01-19 EP EP10700563.9A patent/EP2391603B1/en active Active
- 2010-01-20 US US12/690,128 patent/US20100197715A1/en not_active Abandoned
- 2010-01-25 TW TW099101973A patent/TWI403322B/zh not_active IP Right Cessation
- 2010-01-26 AR ARP100100160A patent/AR075160A1/es not_active Application Discontinuation
-
2011
- 2011-06-07 ZA ZA2011/04237A patent/ZA201104237B/en unknown
- 2011-06-10 CO CO11072655A patent/CO6341621A2/es active IP Right Grant
- 2011-06-20 IL IL213672A patent/IL213672A0/en unknown
- 2011-06-21 CR CR20110348A patent/CR20110348A/es unknown
- 2011-07-11 EC EC2011011196A patent/ECSP11011196A/es unknown
-
2013
- 2013-02-14 US US13/766,840 patent/US9067911B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL213672A0 (en) | 2011-07-31 |
| EP2391603B1 (en) | 2014-01-08 |
| RU2011134960A (ru) | 2013-03-10 |
| SG173116A1 (en) | 2011-08-29 |
| AR075160A1 (es) | 2011-03-16 |
| JP2012515744A (ja) | 2012-07-12 |
| AU2010209816A1 (en) | 2011-08-11 |
| CR20110348A (es) | 2011-09-06 |
| US20100197715A1 (en) | 2010-08-05 |
| TW201032803A (en) | 2010-09-16 |
| CO6341621A2 (es) | 2011-11-21 |
| JP5552494B2 (ja) | 2014-07-16 |
| US20130158050A1 (en) | 2013-06-20 |
| NZ593279A (en) | 2013-03-28 |
| ZA201104237B (en) | 2012-02-29 |
| CN102292320A (zh) | 2011-12-21 |
| US9067911B2 (en) | 2015-06-30 |
| CA2746967A1 (en) | 2010-08-05 |
| CN102292320B (zh) | 2014-07-02 |
| WO2010086251A1 (en) | 2010-08-05 |
| MA32947B1 (fr) | 2012-01-02 |
| TWI403322B (zh) | 2013-08-01 |
| ES2445143T3 (es) | 2014-02-28 |
| KR20110107863A (ko) | 2011-10-04 |
| KR101289577B1 (ko) | 2013-07-24 |
| BRPI1007410A2 (pt) | 2016-02-16 |
| MX2011007272A (es) | 2011-08-08 |
| ECSP11011196A (es) | 2011-08-31 |
| EP2391603A1 (en) | 2011-12-07 |
| PE20120500A1 (es) | 2012-05-04 |
| RU2517701C2 (ru) | 2014-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA104611C2 (en) | Aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitors | |
| AR060489A1 (es) | Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol | |
| NZ631477A (en) | Substituted pyrrolidine-2-carboxamides | |
| MX2011009807A (es) | Compuestos. | |
| MY155653A (en) | Triazine compounds as p13 kinase and mtor inhibitors | |
| EA201591078A1 (ru) | Пептиды в качестве агонистов окситоцина | |
| AR078756A1 (es) | Moduladores alostericos positivos (map) | |
| MX2015017343A (es) | Derivados de pirrolopiridina o pirazolopiridina. | |
| MX2012006789A (es) | Derivados de etinilo. | |
| AU2006325931A8 (en) | Amine compound and use thereof for medical purposes | |
| MX2012002149A (es) | Compuestos que contienen nitrogeno y composiciones farmaceuticas de los mismos para el tratamiento de fibrilacion auricular. | |
| IN2014CN02478A (ru) | ||
| EA201590438A1 (ru) | 2-оксо-2,3-дигидроиндолы для лечения расстройств центральной нервной системы | |
| MY163164A (en) | Ethynyl derivatives as positive allosteric modulators of the mglur5 | |
| MX2012002256A (es) | Antagonistas carbociclicos de receptores de inhibidores de transportador de glicina 1 (glty1). | |
| MX2013001965A (es) | Compuestos disustituidos de tetrahidrofuranilo como antagonistas de receptor de bradiquinina b1 | |
| MX2011009746A (es) | Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica. | |
| WO2008106125A3 (en) | Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists | |
| WO2008031771A3 (en) | 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression | |
| AR081382A1 (es) | Derivados de n-heterocicloalquil bipirrolidinilfenil amida sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades del sistema nervioso central. | |
| EA201000832A1 (ru) | Замещённые 3-гидроксипиридины и содержащие их фармацевтические композиции | |
| EA201291281A1 (ru) | Производные хинолизидина и индолизидина | |
| MX2013005568A (es) | Derivado de sulfuro de difenilo y producto farmaceutico que contiene el mismo como ingrediente activo. | |
| SG153774A1 (en) | New 1h-indol-1-yl-urea compounds, a process for their preparation and pharmaceutical compositions containing them | |
| WO2013113946A3 (en) | Process for the preparation of optically pure fesoterodine derivatives |